Answers are grounded in this paper and cite their sources.
It has been recently proved that n-dipropylacetate increases the level of cerebral γ-aminobutyric acid. Intravenous injections of various doses of the former were administered to eight baboons (Papio papio) that were more or less photosensitive and exhibited convulsive seizures. The results show that n-dipropylacetate can protect (although usually only briefly) against clinical manifestations, and less effectively against EEG manifestations, induced by intermittent light stimulation. Furthermore, protection against grand-mal discharges seems to outlast protection against myoclonic discharges.
No takes yet. Share an insight, caveat, or question.
Patry et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: